Plandai Biotech Company Management Evaluation
| PLPL Stock | USD 0.0002 0.0001 100.00% |
Plandai Biotech employs about 250 people. The company is managed by 3 executives with a total tenure of roughly 14 years, averaging almost 4.0 years of service per executive, having 83.33 employees per reported executive. Inspection of Plandai Biotech's management performance can provide insight into the company performance.
| Roger BaylisDuffield Chairman Chairman of the Board, CEO, CFO |
| Ezra Jones President Vice President of Sales and Marketing |
Plandai |
Plandai Biotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.2096) % which means that it has lost $0.2096 on every $100 spent on assets. This is way below average. Plandai Biotech's management efficiency ratios could be used to measure how well Plandai Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Plandai Biotech Workforce Comparison
Plandai Biotech is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 560. Plandai Biotech totals roughly 250 in number of employees claiming about 45% of equities under Health Care industry.
Plandai Biotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Plandai Biotech Price Series Summation is a cross summation of Plandai Biotech price series and its benchmark/peer.
Plandai Biotech Notable Stakeholders
A Plandai Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Plandai Biotech often face trade-offs trying to please all of them. Plandai Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Plandai Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Roger BaylisDuffield | Chairman of the Board, CEO, CFO | Profile | |
| Ezra Jones | Vice President of Sales and Marketing | Profile | |
| Callum BaylisDuffield | Chief Pres | Profile |
About Plandai Biotech Management Performance
The success or failure of an entity such as Plandai Biotech often depends on how effective the management is. Plandai Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Plandai management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Plandai management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. Planda Biotechnology, Inc. is based in London, the United Kingdom. Diamond Ranch is traded on OTC Exchange in the United States.
Plandai Biotech Workforce Analysis
Traditionally, organizations such as Plandai Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Plandai Biotech within its industry.Plandai Biotech Manpower Efficiency
Return on Plandai Biotech Manpower
| Revenue Per Employee | 1.6K | |
| Revenue Per Executive | 137.3K | |
| Net Loss Per Employee | 16K | |
| Net Loss Per Executive | 1.3M |
Other Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.